Finance

Lists
KYMR:NASDAQ
Kymera Therapeutics Inc
$112.00
+0.04%
(+0.050) 1D
$112.00
0.00% (0.00)
After hours
Closed: Sep 28, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYMR...
Open
$111.95
High
$113.60
Low
$110.51
Mkt. cap
9.31B
Avg. vol.
701.70K
Volume
88.00
52-wk high
$130.05
52-wk low
$54.09
EPS
-$3.24
Beta
1.96
Shares outstanding
83.15M
No. of employees
273
Open
$111.95
High
$113.60
Low
$110.51
Mkt. cap
9.31B
Avg. vol.
701.70K
Volume
88.00
52-wk high
$130.05
52-wk low
$54.09
EPS
-$3.24
Beta
1.96
Shares outstanding
83.15M
No. of employees
273
News stories
From web sources and news partners
About Kymera Therapeutics Inc
CEO-
Employees273
Founded2015
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitekymeratx.com
Analyst ratings
Based on 17 analysts giving stock ratings to KYMR in the past 3 months
Strong buy
Buy
15
Hold
2
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for KYMR in the last 3 months.
Highest
Current $112.00
$180.00 (+60.71%)
Average
$141.18 (+26.05%)
Lowest
$112.00 (0.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Cheng
J.P. Morgan
Buy
Reiterated
$140.00
+25%
09/28/2026
Biren Amin
Piper Sandler
Buy
Maintained
$140.00
+25%
09/23/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$152.00
+35.7%
09/22/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
$144.00
+28.6%
09/14/2026
Andy Chen
Wolfe Research
Buy
Upgraded
$180.00
+60.7%
09/10/2026
Brian Abrahams
RBC Capital
Hold
Maintained
$112.00
0%
09/02/2026
Bradley Canino
Guggenheim
Buy
Reiterated
$170.00
+51.8%
08/30/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$151.00
+34.8%
08/27/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$135.00
+20.5%
08/06/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
$129.00
+15.2%
08/06/2026
David Dai
UBS
Buy
Maintained
$128.00
+14.3%
08/05/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
$134.00
+19.6%
08/06/2026
Geoff Meacham
Citi
Buy
Maintained
$135.00
+20.5%
08/06/2026
Eliana Merle
Barclays
Buy
Maintained
$139.00
+24.1%
08/06/2026
David Hoang
Deutsche Bank
Hold
Initiated
$120.00
+7.1%
07/29/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
$140.00
+25%
07/16/2026
Daniel Giraldo
Bank of America Securities
Buy
Reiterated
$125.00
+11.6%
06/29/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
$136.00
+21.4%
06/29/2026
Mayank Mamtani
B. Riley Securities
Buy
Reiterated
$155.00
+38.4%
06/29/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
$155.00
+38.4%
06/26/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$116.00
+3.6%
06/26/2026
Jeet Mukherjee
BTIG
Buy
Maintained
$134.00
+19.6%
06/25/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/05/2026
Kelly Shi
Jefferies
Buy
Initiated
$110.00
-1.8%
03/15/2026
Faisal Khurshid
Jefferies
Buy
Initiated
$110.00
-1.8%
03/15/2026
Sudan Loganathan
Stephens
Buy
Maintained
$100.00
-10.7%
03/02/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$120.00
+7.1%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.76M
2.87M
34.36M
65.00M
Cost of goods sold
74.09M
83.83M
98.16M
119.48M
Cost of revenue
74.09M
83.83M
98.16M
119.48M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.34M
16.94M
20.36M
21.13M
Operating expense
17.34M
16.94M
20.36M
21.13M
Total operating expenses
91.43M
100.77M
118.52M
140.61M
Operating income
-88.67M
-97.90M
-84.15M
-75.61M
Other non operating income
-
-
5.00K
-25.00K
EBT including unusual items
-82.18M
-86.98M
-69.23M
-61.21M
EBT excluding unusual items
-78.32M
-86.98M
-69.23M
-61.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-82.18M
-86.98M
-69.23M
-61.21M
Net profit margin
-2,973.05%
-3,030.70%
-201.47%
-94.17%
Earnings per share
-0.94
-0.98
-0.71
-0.62
Interest and investment income
10.44M
11.00M
14.98M
14.48M
Interest expense
-98.00K
-90.00K
-66.00K
-56.00K
Net interest expenses
10.35M
10.92M
14.92M
14.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
-85.82M
-97.46M
-82.13M
-74.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps